Innovid

This stock was crushed after going public via a SPAC transaction and is a bargain at current trading levels. Innovid Corp. (NYSE: CTV) operates as a connected TV advertising delivery and measurement platform. It offers marketer solutions, such as connected TV advertising, ad serving, creative management, advertising measurement, and identity resolution; publisher solutions; and creative ad authoring tools. The company serves brands, agencies and publishers in the Americas, Europe and the Asia Pacific.

Founded in 2007, Innovid is uniquely equipped to support the transition of traditional linear ad investment to connected TV advertising (CTV). The company’s core ad delivery solution provides advertisers a consolidated interface to streamline ad serving, operating as the infrastructure through which CTV ads are delivered across all media including direct buys, programmatic inventory, the open web and walled gardens. Innovid’s platform also allows advertisers to tap into value-added features designed to increase the performance of advertising creative through personalization and interactivity, as well as provide deeper insights into CTV advertising reach, frequency and engagement.

Needham recently started coverage on the stock and has a $10 price target. The consensus target is $11.00., and on Friday the shares closed trading at $6.65.

Pear Therapeutics

This is another solid play for investors looking for microcap biotech ideas. Pear Therapeutics Inc. (NASDAQ: PEAR) engages in developing and commercializing software-based medicines.

The company has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions. Its products include PearConnect, a patient service center for prescription digital therapeutics; reSET for the treatment of substance use disorder; reSET-O for the treatment of opioid use disorder; and Somryst for the treatment of chronic insomnia.

Crossroads, a national leader in the treatment of opioid use disorder, began implementing Pear’s reSET-O PDT technology in its centers across western Pennsylvania in January 2020. Now, Pear’s reSET and reSET-O PDTs have the potential to reach thousands of additional patients per month as a standard of care for eligible patients in Crossroads locations across the rest of Pennsylvania and into Kentucky, New Jersey and Virginia.

Citigroup started coverage last week. Its $13 price target is lower than the $14.40 consensus target, but the stock was trading at $6.20, up a stunning 22% on Friday.

Get Our Free Investment Newsletter

I have read, and agree to the Terms of Use

These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. While not suited for all investors, they are not penny stocks with absolutely no track record or liquidity, and major Wall Street firms have research coverage.

Sponsored: Tips for Investing

A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.

Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.